Institut Cochin (Inserm/CNRS/Université de Paris)
Telephone number provided upon request
Certain bacteria of the intestinal microbiota (shown in red) are able to penetrate the normally sterile mucus layer (shown in green). © Benoit Chassaing
Diet is believed to play a role in triggering intestinal inflammation that can lead to the development of certain conditions, such as Crohn’s disease. Researchers from Inserm, CNRS and Université de Paris have shown that the emulsifiers present in many processed foods could have a harmful impact on specific bacteria in the gut microbiota, leading to chronic inflammation. Their findings have been published in Cell Reports.
The prevalence of chronic inflammatory bowel disease is increasing in all countries of the world and is thought to affect nearly 20 million people. Characterized by inflammation of the wall of part of the digestive tract, these conditions include Crohn’s disease and ulcerative colitis.
Several factors, both genetic and environmental, have been implicated in explaining the intestinal inflammation associated with these diseases. For several years, Inserm researcher Benoît Chassaing and his team at Institut Cochin (Inserm/CNRS/Université de Paris) have studied the role of diet, particularly the impact of certain additives such as emulsifiers.
Widely used by the food industry in many processed products, the purpose of emulsifiers is to improve texture and extend shelf life. For example, lecithin and polysorbates ensure the smooth texture of mass-produced ice cream and prevent it from melting too quickly once served.
This led to their hypothesis that the emulsifiers would impact only specific bacteria, which are harmless under “normal” conditions but have the potential to cause disease. It is only in the presence of emulsifiers that these bacteria would be able to promote the development of chronic intestinal inflammation and its associated diseases.
E. coli as a model
As part of their study published in Cell Reports, the researchers used two mouse models: one without a microbiota and the other with a simple microbiota containing only eight species of bacteria. They colonized them with a strain of Escherichia coli (“AIEC bacteria”) associated with Crohn’s disease.
The researchers were interested in the effects of two emulsifiers administered following the colonization of the mice by the AIEC bacteria. Although the consumption of the emulsifiers had no harmful effects on the animals in the absence of these bacteria, they observed the development of chronic intestinal inflammation and metabolic deregulation when they were present. The presence of both the AIEC bacteria and the emulsifier was necessary and sufficient to induce chronic intestinal inflammation.
Further analysis revealed that when these bacteria were in contact with the emulsifiers, they over-expressed groups of genes that increased their virulence and propensity to induce inflammation. “We were able to identify a mechanism by which dietary emulsifiers can promote chronic intestinal inflammation in people who harbor certain bacteria, such as AIEC bacteria, in their digestive tract,” says Benoît Chassaing , who coordinated the study.
The next step is to list all the bacteria that have the same effects in contact with these food additives.
“And while it is illusory to think that we can banish emulsifiers from our diet, the models and methodologies we have developed here will also allow us to test the action of several types of emulsifiers on the microbiota in order to identify those without harmful effects, and thus encourage their use,” concludes Chassaing.
 An emulsifier is a compound that has an affinity for both water and oil and allows the different phases of a compound to remain mixed together.
Les résultats d'une méta-analyse montrent qu’un traitement par corticoïdes diminuerait de 21% le risque de mortalité des formes sévères de Covid-19. ...
Dietary Emulsifiers Directly Impact Adherent-Invasive E. coli Gene Expression to Drive Chronic Intestinal Inflammation
Emilie Viennois1,2 Alexis Bretin2, Philip E. Dube3, Alexander C. Maue3 Charlene J.G. Dauriat4 Nicolas Barnich5 Andrew T. Gewirtz2 and Benoit Chassaing2,4,6,7*
1 INSERM, U1149, Center of Research on Inflammation, Universite´ de Paris, Paris, France
2 Institute for Biomedical Sciences, Center for Inflammation, Immunity and Infection, Digestive Disease Research Group, Georgia State University, Atlanta, GA, USA
3 Taconic Biosciences Inc, Rensselaer, NY, USA
4 INSERM U1016, team ‘‘Mucosal microbiota in chronic inflammatory diseases’’, CNRS UMR 8104, Université de Paris, Paris, France
5 Université Clermont Auvergne/Inserm U1071 USC-INRA 2018, Microbes, Intestin, Inflammation et Susceptibilite´ de l’Hote (M2iSH), Clermont-Ferrand, France
6 Neuroscience Institute, Georgia State University, Atlanta, GA, USA
7 Lead contact
Cell Reports, octobre 2020. DOI : https://doi.org/10.1016/j.celrep.2020.108229